MS Pharma Takes MENA Rights To Lucentis Rival

Company Will Register And Market Bioeq-Formycon FYB201 Ranibizumab Candidate

 
• By David Wallace
  
Eye Close-Up Africa Pupil
MS Pharma has rights to ranibizumab in North Africa and the Middle East • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business